<?xml version="1.0" encoding="iso-8859-1" ?>
<newsitem itemid="179444" id="root" date="1996-11-11" xml:lang="en">
<title>USA: Glaxo, Ivax sign Easi-Breath pact.</title>
<headline>Glaxo, Ivax sign Easi-Breath pact.</headline>
<dateline>MIAMI 1996-11-11</dateline>
<text>
<p>IVAX Corp said Monday that its subsidiary, Norton Healthcare Ltd, intends to enter a definitive licensing agreement with Glaxo Wellcome Plc for Ivax's Easbreathing device.</p>
<p>IVAX said its subsidiary has executed a memorandum of understanding with Glaxo for the deal, reflecting the parties' intent to sign a definitive license agreement by the end of 1996.  </p>
<p>Though the financial terms of the working relationship established by the license agreement are confidential, IVAX said it will receive a combination of fixed payments and royalties. Fixed payments are expected to total about $72 million, of which a proportion will be paid in 1996.</p>
<p>In addition to these fixed payments, the agreement will provide for substantial additional annual volume/revenue related royalties which will continue for the duration of the license, IVAX said.</p>
<p>The proposed agreement will significantly expand terms of an existing IVAX/Glaxo Easi-Breathe agreement, which provides Glaxo with certain rights to the proprietary inhaler.</p>
<p>Under the proposed agreement, Glaxo Wellcome will license the right to use Easi-Breathe for its range of inhaled products and for products to which it has exclusive rights.</p>
<p>The license will grant Glaxo Wellcome the exclusive right to use Easi-Breathe for these compounds on a worldwide basis, except in certain countries where IVAX has pre-existing agreements for use of Easi-Breathe, a statement from IVAX said.</p>
</text>
<copyright>(c) Reuters Limited 1996</copyright>
<metadata>
<codes class="bip:countries:1.0">
  <code code="USA">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-11-11"/>
  </code>
</codes>
<codes class="bip:industries:1.0">
  <code code="I25700">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-11-11"/>
  </code>
</codes>
<codes class="bip:topics:1.0">
  <code code="C33">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-11-11"/>
  </code>
  <code code="CCAT">
    <editdetail attribution="Reuters BIP Coding Group" action="confirmed" date="1996-11-11"/>
  </code>
</codes>
<dc element="dc.date.created" value="1996-11-11"/>
<dc element="dc.publisher" value="Reuters Holdings Plc"/>
<dc element="dc.date.published" value="1996-11-11"/>
<dc element="dc.source" value="Reuters"/>
<dc element="dc.creator.location" value="MIAMI"/>
<dc element="dc.creator.location.country.name" value="USA"/>
<dc element="dc.source" value="Reuters"/>
</metadata>
</newsitem>
